Financials

News Ideas Technicals

1737 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TAIYEN BIOTECH CO operating, investing, and financing activities

1737 free cash flow for Q1 24 is 62.55 M TWD. For 2023, 1737 free cash flow was 184.75 M TWD and operating cash flow was 526.4 M TWD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—